Brief: Senti Biosciences Q1 Net Income USD -14.112 Million
06/05/2025 21:35
May 06 (Reuters) - Senti Biosciences Q1 EPS USD -1.41. Q1 operating expenses USD 16.397 million Q1 operating income USD -16.397 million
Recent news on Senti Biosciences Holdings
See all newsBrief: Senti Biosciences Says Offering 15.97 Million Shares Of Common Stock For Resale By Selling Securityholder
Senti Biosciences Q1 net loss narrows on cost reduction
Brief: Senti Biosciences Holdings Announces Positive FDA RMAT Meeting on Registrational Clinical and CMC Strategy
Brief: Senti Biosciences Announces Holding Company Reorganization Effective By April 16, 2026 - SEC Filing
Senti Biosciences Q4 revenue misses analyst estimates